Tan, Yossan-Var <br/><br/>
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.  [electronic resource] 

 -  Brain, behavior, and immunity  Feb 2015 
 - 167-175 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1090-2139 
<br/><br/><label>Standard No.: </label>10.1016/j.bbi.2014.09.020  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Cell Proliferation<br/>Encephalomyelitis, Autoimmune, Experimental--immunology<br/>Gene Expression<br/>Interferon-gamma--metabolism<br/>Interleukin-17--metabolism<br/>Interleukin-4--metabolism<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>RNA, Messenger--metabolism<br/>Receptors, Vasoactive Intestinal Peptide, Type II--genetics<br/>Spinal Cord--pathology<br/>T-Lymphocytes, Regulatory--metabolism